JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, C.
Right arrow Articles by Reith, M. E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, C.
Right arrow Articles by Reith, M. E. A.

Vol. 282, Issue 2, 920-927, 1997

WIN 35,428 and Mazindol Are Mutually Exclusive in Binding to the Cloned Human Dopamine Transporter1

Cen Xu and Maarten E. A. Reith

Department of Biomedical and Therapeutic Sciences, University of Illinois, College of Medicine, Peoria, Illinois

It has been suggested that cocaine and mazindol bind to separate sites on the dopamine transporter. In the present study, we address this issue by examining the inhibition by mazindol of the binding of [3H]WIN 35,428 ([3H]2beta -carbomethyoxy-3beta -(4-fluorophenyl)-tropane), a phenyltropane analog of cocaine, and the inhibition by WIN 35,428 of [3H]mazindol binding to the cloned human dopamine transporter expressed in C6 glioma cells. The design involved the construction of inhibition curves at six widely different radioligand levels, enabling the distinction between the nonlinear hyperbolic competition (i.e., negative allosteric) model and the competitive (i.e., mutually exclusive binding) model. Nonlinear computer curve-fitting analysis indicated no difference in the goodness of fit between the two models; the negative allosteric model indicated an extremely high allosteric constant of ~ >= 100, which practically equates to the competitive model. The present results suggest that complex interactions reported between cocaine and mazindol in inhibiting dopamine transport are beyond the level of ligand recognition.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
K. Y. Little, L. W. Elmer, H. Zhong, J. O. Scheys, and L. Zhang
Cocaine Induction of Dopamine Transporter Trafficking to the Plasma Membrane
Mol. Pharmacol., February 1, 2002; 61(2): 436 - 445.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. R. Zahniser, G. A. Larson, and G. A. Gerhardt
In Vivo Dopamine Clearance Rate in Rat Striatum: Regulation by Extracellular Dopamine Concentration and Dopamine Transporter Inhibitors
J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 266 - 277.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. E. A. Reith, J. L. Berfield, L. C. Wang, J. V. Ferrer, and J. A. Javitch
The Uptake Inhibitors Cocaine and Benztropine Differentially Alter the Conformation of the Human Dopamine Transporter
J. Biol. Chem., July 27, 2001; 276(31): 29012 - 29018.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.